A detailed history of Quadrature Capital LTD transactions in Baxter International Inc stock. As of the latest transaction made, Quadrature Capital LTD holds 9,179 shares of BAX stock, worth $317,960. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,179
Holding current value
$317,960
% of portfolio
0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$32.87 - $43.55 $301,713 - $399,745
9,179 New
9,179 $307 Million
Q1 2023

May 15, 2023

BUY
$37.58 - $52.57 $287,299 - $401,897
7,645 Added 12.54%
68,602 $2.78 Million
Q4 2022

Feb 14, 2023

BUY
$49.7 - $57.71 $3.03 Million - $3.52 Million
60,957 New
60,957 $3.11 Million
Q4 2021

Feb 14, 2022

SELL
$74.57 - $87.19 $1.43 Million - $1.67 Million
-19,116 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$73.77 - $83.61 $696,093 - $788,943
9,436 Added 97.48%
19,116 $1.54 Million
Q2 2021

Aug 16, 2021

SELL
$80.5 - $88.01 $2.15 Million - $2.35 Million
-26,755 Reduced 73.43%
9,680 $779,000
Q1 2021

May 17, 2021

BUY
$76.38 - $86.03 $1.3 Million - $1.47 Million
17,065 Added 88.1%
36,435 $3.07 Million
Q4 2020

Feb 16, 2021

SELL
$75.39 - $82.36 $3.97 Million - $4.33 Million
-52,603 Reduced 73.09%
19,370 $1.55 Million
Q3 2020

Nov 13, 2020

BUY
$78.33 - $90.73 $4.6 Million - $5.33 Million
58,722 Added 443.15%
71,973 $5.79 Million
Q2 2020

Aug 14, 2020

BUY
$78.66 - $94.14 $792,656 - $948,648
10,077 Added 317.49%
13,251 $1.14 Million
Q4 2018

Feb 13, 2019

SELL
$61.45 - $77.8 $1.53 Million - $1.94 Million
-24,880 Reduced 88.69%
3,174 $208,000
Q4 2017

Feb 12, 2018

BUY
$61.45 - $66.05 $1.72 Million - $1.85 Million
28,054
28,054 $0

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $17.5B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Quadrature Capital LTD Portfolio

Follow Quadrature Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrature Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Quadrature Capital LTD with notifications on news.